Systemic sclerosis (scleroderma) and Heart palpitations

Summary:

Heart palpitations is found among people with Systemic sclerosis (scleroderma), especially for people who are female, 60+ old.

The study analyzes which people have Heart palpitations with Systemic sclerosis (scleroderma). It is created by eHealthMe based on reports of 59 people who have Systemic sclerosis (scleroderma) from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Systemic sclerosis (scleroderma)?

Systemic sclerosis (scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin) is found to be associated with 495 drugs and 857 conditions by eHealthMe. Check the latest studies of Systemic sclerosis (scleroderma).

What is Heart palpitations?

Heart palpitations (feelings or sensations that your heart is pounding or racing) is found to be associated with 2,444 drugs and 3,634 conditions by eHealthMe. Check the latest studies of Heart palpitations.



On Jul, 14, 2026

59 people who have Systemic Sclerosis (Scleroderma) and Heart Palpitations are studied.

Would you have Heart palpitations when you have Systemic sclerosis (scleroderma)?

Gender of people who have Systemic Sclerosis (Scleroderma) and experienced Heart Palpitations *:

  • female: 94.92 %
  • male: 5.08 %

Age of people who have Systemic Sclerosis (Scleroderma) and experienced Heart Palpitations *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 6.52 %
  • 40-49: 19.57 %
  • 50-59: 19.57 %
  • 60+: 54.35 %

Common co-existing conditions for these people *:

  1. Pulmonary Hypertension (increase in blood pressure in the lung artery): 35 people, 59.32%
  2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 20 people, 33.90%
  3. High Blood Pressure: 4 people, 6.78%
  4. Dyspnea (difficult or laboured breathing): 3 people, 5.08%
  5. Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 3 people, 5.08%
  6. Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 3.39%
  7. Skin Ulcer: 2 people, 3.39%
  8. Cardiac Failure: 2 people, 3.39%
  9. Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 3.39%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 3.39%

Common drugs taken by these people *:

  1. Letairis: 31 people, 52.54%
  2. Adcirca: 16 people, 27.12%
  3. Ambrisentan: 13 people, 22.03%
  4. Tyvaso: 9 people, 15.25%
  5. Orenitram: 8 people, 13.56%
  6. Veletri: 8 people, 13.56%
  7. Revatio: 7 people, 11.86%
  8. Pantoprazole: 6 people, 10.17%
  9. Ventolin Hfa: 5 people, 8.47%
  10. Miralax: 4 people, 6.78%

Common symptoms for these people *:

  1. Dyspnea (difficult or laboured breathing): 19 people, 32.20%
  2. Fatigue (feeling of tiredness): 12 people, 20.34%
  3. Chest Pain: 11 people, 18.64%
  4. Oedema (fluid collection in tissue): 10 people, 16.95%
  5. Dizziness: 10 people, 16.95%
  6. Oedema Peripheral (superficial swelling): 8 people, 13.56%
  7. Diarrhea: 8 people, 13.56%
  8. Nausea (feeling of having an urge to vomit): 7 people, 11.86%
  9. Headache (pain in head): 7 people, 11.86%
  10. Cough: 7 people, 11.86%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Heart palpitations?

- Check whether Heart palpitations is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Heart palpitations:

All the conditions that are associated with Heart palpitations:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Heart palpitations and Systemic sclerosis (scleroderma), and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: